Key statistics
On Friday, Cellectar Biosciences Inc (CLRB:NAQ) closed at 1.58, 14.08% above the 52 week low of 1.39 set on Nov 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.56 |
---|---|
High | 1.61 |
Low | 1.52 |
Bid | 1.58 |
Offer | 1.61 |
Previous close | 1.58 |
Average volume | 804.76k |
---|---|
Shares outstanding | 40.57m |
Free float | 37.02m |
P/E (TTM) | -- |
Market cap | 64.10m USD |
EPS (TTM) | -1.67 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
- Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
- Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer